Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles
- 1 September 1985
- journal article
- Published by Springer Nature in Nature
- Vol. 317 (6034), 248-250
- https://doi.org/10.1038/317248a0
Abstract
Vasopressin (VP) potentiates the effect of corticotropin-releasing factor (CRF) on the secretion of adrenocorticotropic hormone (ACTH) from anterior pituitary cells in vitro, and both CRF and VP have been found in portal blood. These data support the hypothesis that VP acts synergistically with CRF to cause the secretion of ACTH in vivo but the origin of the CRF and VP, and the physiology of their release, have not been precisely defined. Parvocellular cell bodies in the paraventricular nucleus (PVN) which project to the external zone of the median eminence can be stained for both CRF and VP after adrenalectomy, and there is light microscopic immunocytochemical evidence that neurophysin (NP) may be located within some of the CRF-containing axons. Electron microscopic immunocytochemical studies have demonstrated the presence of CRF, VP and its 'carrier' protein, VP-associated neurophysin (NP-VP) in 100-nm neurosecretory vesicles (NSVs) in axons terminating near the portal capillary plexus in the external zone of the median eminence. If these peptides are extensively co-localized in the same NSVs in the median eminence, then coordinate secretion of CRF and VP in vivo is obligatory, at least in some physiological circumstances. We demonstrate in this report, using post-embedding electron microscopic immunocytochemistry on serial ultrathin sections, that CRF, VP and NP-VP are contained not only in the same axons and terminals, but in the same 100-nm NSVs in the median eminence of both normal and adrenalectomized rats. In addition, in the normal rat median eminence 44% of the CRF-positive axons and terminals stained strongly for VP and NP-VP, whereas in the adrenalectomized rat virtually all the CRF-positive structures in the median eminence showed strong staining for VP and NP-VP, indicating a transformation of one subpopulation of CRF-positive axons and terminals by adrenalectomy.Keywords
This publication has 27 references indexed in Scilit:
- CENTRAL MODULATION OF IMMUNOREACTIVE CORTICOTROPIN-RELEASING FACTOR SECRETION BY ARGININE VASOPRESSINEndocrinology, 1984
- Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal bloodBrain Research, 1983
- Effects of Synthetic Ovine Corticotropin-Releasing Factor, Glucocorticoids, Catecholamines, Neurohypophysial Peptides, and Other Substances on Cultured Corticotropic Cells*Endocrinology, 1983
- Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique.Journal of Histochemistry & Cytochemistry, 1983
- Ability of the CRF Immunoreactive Neurons of the Paraventricular Nucleus to Produce a Vasopressin-Like MaterialNeuroendocrinology, 1983
- PRESENCE OP CORTICOTROPIN RELEASING FACTOR-LIKE IMMUNOREACTIVITY IN HYPOPHYSIAL PORTAL BLOODEndocrinology, 1982
- Corticotropin releasing activity of the new CRF is potentiated several times by vasopressinNature, 1982
- In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressinPeptides, 1982
- VASOPRESSIN AND CORTICOTROPIN-RELEASING FACTOR: AN AXONAL PATHWAY TO PORTAL CAPILLARIES IN THE ZONA EXTERNA OF THE MEDIAN EMINENCE CONTAINING VASOPRESSIN AND ITS INTERACTION WITH ADRENAL CORTICOIDSAnnals of the New York Academy of Sciences, 1977
- Potentiation by Vasopressin of Corticotropin Release Induced by Corticotropin-Releasing Factor1Endocrinology, 1971